Rang	Name	Position
1	Mr. Andrew J. Hirsch M.B.A.	CEO, President & Director
2	Dr. Kenneth C. Anderson M.D., Ph.D.	Co-Founder, Independent Director & Member of Scientific Advisory Board
3	Ms. Kendra R. Adams	Principal Accounting Officer, CFO, Head of Corporate Affairs & Treasurer
4	Dr. Leonard M. J. Reyno M.D.	Chief Medical Officer
5	Dr. Nathanael S. Gray Ph.D.	Co-Founder & Member of Scientific Advisory Board
6	Ms. Courtney Solberg	Senior Manager of Investor Relations
7	Ms. Kelly A. Schick	Chief People Officer
8	Dr. Isabel Chiu Ph.D.	Senior Vice President of Strategic Alliances & Business Development
9	Dr. Christopher Nasveschuk	Senior Vice President of Chemistry
10	Mr. Roy Pollock Ph.D.	Senior Vice President of Biological Sciences

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Morgan Stanley - Brokerage Accounts	7,37%	31,84 Mio. USD
2	RA Capital Management, LLC	6,50%	28,08 Mio. USD
3	Lynx1 Capital Management, LP	5,96%	25,72 Mio. USD
4	Squadron Capital Management LLC	5,85%	25,27 Mio. USD
5	Bain Capital Life Sciences Investors, LLC	5,83%	25,17 Mio. USD
6	Citadel Advisors Llc	3,40%	14,70 Mio. USD
7	Vanguard Capital Management, LLC	3,14%	13,56 Mio. USD
8	Wasatch Advisors LP	2,86%	12,37 Mio. USD
9	Two Sigma Investments LLC	2,82%	12,18 Mio. USD
10	Soleus Capital Management, L.P.	2,75%	11,86 Mio. USD
11	JPMorgan Chase & Co	2,62%	11,31 Mio. USD
12	Renaissance Technologies Corp	2,00%	8,64 Mio. USD
13	The Goldman Sachs Group Inc	1,94%	8,38 Mio. USD
14	Bank of America Corp	1,92%	8,28 Mio. USD
15	BlackRock Inc	1,67%	7,19 Mio. USD
16	SILVERARC CAPITAL MANAGEMENT, LLC	1,55%	6,71 Mio. USD
17	Acadian Asset Management LLC	1,54%	6,64 Mio. USD
18	D. E. Shaw & Co LP	1,42%	6,11 Mio. USD
19	Patient Square Capital LP	1,31%	5,65 Mio. USD
20	HighVista Strategies LLC	1,10%	4,73 Mio. USD